Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Read original at benzingaStocks · News reference
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Read original at benzingaCitigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Read original at benzingaRBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Read original at benzingaFiled: 2026-08-20 AccNo: 0001193125-26-359299 Size: 146 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarFiled: 2026-08-03 AccNo: 0001193125-26-330555 Size: 142 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarRBC Capital analyst Brad Heffern maintains Getty Realty (NYSE:GTY) with a Sector Perform and raises the price target from $35 to $36.
Read original at benzinga